BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2
336 results:

  • 1. The management of uterine tumor resembling an ovarian sex cord tumor (UTROSCT): case series and literature review.
    Lin J; Liu L; Wang L; Ma N; Zhang K; Xie N; Yu H; Deng S; Sun Y
    World J Surg Oncol; 2024 Feb; 22(1):42. PubMed ID: 38310233
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancer.
    Bates M; Mullen D; Lee E; Costigan D; Heron EA; Kernan N; Barry-O'Crowley J; Martin C; Keegan H; Malone V; Brooks RD; Brooks DA; Logan JM; Martini C; Selemidis S; McFadden J; O'Riain C; Spillane CD; Gallagher MF; McCann A; O'Toole S; O'Leary JJ
    Pathol Res Pract; 2024 Jan; 253():155020. PubMed ID: 38103365
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese woman: a three-center case-control study.
    Liu S; Yan Y; Cui Z; Feng H; Zhong F; Liu Z; Li Y; Ou X; Li W
    BMC Cancer; 2023 Nov; 23(1):1149. PubMed ID: 38012622
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Frontiers of ovarian Carcinosarcoma.
    Ismail A; Choi S; Boussios S
    Curr Treat Options Oncol; 2023 Dec; 24(12):1667-1682. PubMed ID: 37938504
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Dual targeting ovarian cancer by Muc16 CAR T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen wt1.
    Mun SS; Meyerberg J; Peraro L; Korontsvit T; Gardner T; Malviya M; Kyi C; O'Cearbhaill RE; Liu C; Dao T; Scheinberg DA
    Cancer Immunol Immunother; 2023 Nov; 72(11):3773-3786. PubMed ID: 37635172
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of RAD51 foci in cancer-associated circulating cells of patients with high-grade serous ovarian cancer: association with treatment outcomes.
    Alizzi Z; Saravi S; Khalique S; McDonald T; Karteris E; Hall M
    Int J Gynecol Cancer; 2023 Sep; 33(9):1427-1433. PubMed ID: 37541687
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. High-grade Serous Carcinoma can Show Squamoid Morphology Mimicking True Squamous Differentiation.
    Tomonobe H; Ohishi Y; Hachisuga K; Yahata H; Kato K; Oda Y
    Am J Surg Pathol; 2023 Sep; 47(9):967-976. PubMed ID: 37382102
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Distinct histological and clinical features associated with pure uterine serous carcinoma: A single institution experience.
    Zhi W; Zhan Y; He C; Jin Y
    Ann Diagn Pathol; 2023 Oct; 66():152173. PubMed ID: 37352704
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. ovarian Mesonephric-Like Adenocarcinoma With Recurrent Liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets.
    Sugitani A; Ogawa A; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
    Int J Surg Pathol; 2024 May; 32(3):578-585. PubMed ID: 37345348
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pathological discrimination between luteinized thecoma associated with sclerosing peritonitis and thecoma.
    Liu J; Wei J; Yang Y; Wei J
    Medicine (Baltimore); 2023 Jun; 102(23):e33911. PubMed ID: 37335673
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma].
    Chang YH; Zou BQ; Cai Y; Yang SD; Zhang Y; Liang JB; Li C
    Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):424-432. PubMed ID: 37188628
    [No Abstract]    [Full Text] [Related]  

  • 12. High-grade serous ovarian carcinoma with a sertoliform pattern associated with BRCA mutation: a clinicopathological and molecular analysis.
    Travaglino A; Santoro A; Arciuolo D; Raffone A; Scaglione G; D'Alessandris N; Valente M; Sfregola S; Fulgione C; Onori ME; Minucci A; Zannoni GF
    Virchows Arch; 2023 Dec; 483(6):879-883. PubMed ID: 37166561
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Uterine choriocarcinoma coexistence with endometroid adenocacinoma: a case report and literature review.
    Bai L; Chen Y; Han L; Zheng A; Mo X
    BMC Womens Health; 2023 May; 23(1):252. PubMed ID: 37165420
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. CREB fusion-associated epithelioid mesenchymal neoplasms of the female adnexa: three cases documenting a novel location of an emerging entity and further highlighting an ambiguous misleading immunophenotype.
    Trecourt A; Macagno N; Ngo C; Philip CA; Lopez J; Ferreira J; Alves-Vale C; Ray-Coquard I; Genestie C; Agaimy A; Devouassoux-Shisheboran M
    Virchows Arch; 2023 Jun; 482(6):967-974. PubMed ID: 37097347
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. ovarian Granulosa Cell Tumor Initially Presenting as a Giant Liver Mass Radiologically Mimicking Primary Cystic Cholangiocarcinoma.
    Qian X; Cong Z; Lai J
    In Vivo; 2023; 37(2):734-737. PubMed ID: 36881092
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Molecular mechanism of Wilms' tumor (wt1) (+/-KTS) variants promoting proliferation and migration of ovarian epithelial cells by bioinformatics analysis.
    Wang X; Zhao J; Zhang Y; Liu Y; Wang J; Shi R; Yuan J; Meng K
    J Ovarian Res; 2023 Feb; 16(1):46. PubMed ID: 36829196
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. cancer-associated mesothelial cell-derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis.
    Bajwa P; Kordylewicz K; Bilecz A; Lastra RR; Wroblewski K; Rinkevich Y; Lengyel E; Kenny HA
    JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795484
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Establishment and preliminary application of organoids in ovarian cancer].
    Zhang L; Meng HY; Zhang YS; Miao HX; Yuan L; Zhou SL; Jiang Y; Wan YC; Cheng WW
    Zhonghua Fu Chan Ke Za Zhi; 2023 Feb; 58(2):112-120. PubMed ID: 36776006
    [No Abstract]    [Full Text] [Related]  

  • 19. NCOA1/2/3 rearrangements in uterine tumor resembling ovarian sex cord tumor: A clinicopathological and molecular study of 18 cases.
    Lu B; Xia Y; Chen J; Tang J; Shao Y; Yu W
    Hum Pathol; 2023 May; 135():65-75. PubMed ID: 36646185
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinicopathologic Features and the Loss of ARID1A Expression in ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas.
    Ok Atılgan A; Özen Ö; Haberal Reyhan AN; Ayhan A
    Int J Surg Pathol; 2023 Jun; 31(4):398-408. PubMed ID: 36452965
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 17.